Details for New Drug Application (NDA): 077243
✉ Email this page to a colleague
The generic ingredient in OLANZAPINE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.
Summary for 077243
Tradename: | OLANZAPINE |
Applicant: | Barr Labs Inc |
Ingredient: | olanzapine |
Patents: | 0 |
Suppliers and Packaging for NDA: 077243
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 077243 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-5245 | 0093-5245-65 | 30 BLISTER PACK in 1 CARTON (0093-5245-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-5245-19) |
OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 077243 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-5246 | 0093-5246-65 | 30 BLISTER PACK in 1 CARTON (0093-5246-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (0093-5246-19) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 5MG | ||||
Approval Date: | Jan 30, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
Approval Date: | Jan 30, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 15MG | ||||
Approval Date: | Jan 30, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription